M&T Bank
FOLD

M&T Bank’s Amicus Therapeutics FOLD Stock Holding History

M&T Bank’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-32,250
Closed -$455K – 1718
2020
Q3 		$455K Buy
32,250
+7,898
+32% +$115K ﹤0.01% 1029
2020
Q2 		$367K Sell
24,352
-2,626
-10% -$32K ﹤0.01% 1094
2020
Q1 		$250K Buy
+26,978
New +$256K ﹤0.01% 1228
2016
Q2 		– Sell
-18,568
Closed -$157K – 1723
2016
Q1 		$157K Buy
+18,568
New +$132K ﹤0.01% 1515
2015
Q3 		– Sell
-13,921
Closed -$198K – 1877
2015
Q2 		$198K Buy
+13,921
New +$167K ﹤0.01% 1787

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

M&T Bank's FOLD Position: Q4 2020 in Review

M&T Bank sold out of Amicus Therapeutics (FOLD) in Q4 2020, closing a stake of 32,250 shares — an estimated $455K sold.

M&T Bank first reported a position in FOLD in Q2 2015 and held it in 5 quarters. The position peaked at $455K in Q3 2020. 272 funds tracked by Wall St. Rank hold FOLD as of Q4 2020.

  • M&T Bank reported no remaining Amicus Therapeutics position as of Q4 2020 after selling out during the quarter.
  • M&T Bank sold 32,250 Amicus Therapeutics shares in Q4 2020, an estimated $455K.
  • M&T Bank first reported a position in Amicus Therapeutics in Q2 2015 and held it in 5 quarters.
  • M&T Bank's Amicus Therapeutics position peaked at $455K in Q3 2020.
  • 272 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2020.

Based on M&T Bank's 13F filing for Q4 2020, filed 12 Feb 2021.